+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cystic Fibrosis Devices Market by Product Type (Diagnostic, Pulmonary Delivery), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Modality, Component, Patient Type - Global Forecast 2025-2030- Product Image
Cystic Fibrosis Devices Market by Product Type (Diagnostic, Pulmonary Delivery), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Modality, Component, Patient Type - Global Forecast 2025-2030- Product Image
Sale

Cystic Fibrosis Devices Market by Product Type (Diagnostic, Pulmonary Delivery), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Modality, Component, Patient Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014637
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cystic fibrosis devices market is experiencing significant transformation, with new advances in patient monitoring, pulmonary therapies, and supply chain strategy redefining operational priorities and decision-making for healthcare leaders and stakeholders.

Market Snapshot: Cystic Fibrosis Devices Market Size & Growth Trajectory

The Cystic Fibrosis Devices Market grew from USD 3.20 billion in 2024 to USD 3.57 billion in 2025, with expectations for continued expansion at a CAGR of 11.18%, reaching USD 6.05 billion by 2030. This upward momentum reflects a robust pipeline of device innovation, broader diagnostic access, and global efforts to enhance patient outcomes for a highly complex chronic respiratory condition.

Scope & Segmentation

  • Product Types: Diagnostic solutions, pulmonary delivery devices, dry powder inhalers, inhalers, metered dose inhalers, soft mist inhalers, and nebulizers (jet, mesh, ultrasonic).
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies, and specialty centers.
  • End Users: Clinics, home care settings, and hospitals.
  • Modalities: Invasive and non-invasive device options.
  • Components: Pumps (peristaltic, syringe), sensors (flow, pressure), and valves.
  • Patient Types: Adult-focused and pediatric-focused device categories.
  • Regions: Coverage includes Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple key countries), and Asia-Pacific (including China, India, Japan, and others).
  • Companies Profiled: Koninklijke Philips N.V., Baxter International Inc., Drive DeVilbiss Healthcare, PARI GmbH, Vyaire Medical, Smiths Group, Teleflex, Omron, ResMed, Fisher & Paykel Healthcare.

Key Takeaways: Market Forces and Innovation Drivers

  • Early adoption of molecular diagnostics enhances detection accuracy, shaping individualized care pathways and improving the clinical value of cystic fibrosis devices for both adult and pediatric patients.
  • Portable, home-use device formats reflect the push toward healthcare decentralization by empowering individuals to manage therapy outside of clinical settings, supporting higher adherence and better outcomes.
  • Growing integration of digital health technologies, including smart sensors and telemonitoring in inhalers and nebulizers, bridges the gap between real-time data and proactive care management.
  • Collaborative research partnerships and rapid advancements in materials science and 3D printing are facilitating the shift toward ergonomic, patient-centric device design.
  • Segmentation by distribution channel shows that hospital pharmacies are primary hubs for acute needs, while online and retail pharmacies support convenience-driven adoption in ambulatory populations.
  • Market competition is shaped by both broad-based product portfolios of major manufacturers and focused niche specialists who address unmet needs through strategic alliances and acquisitions.

Tariff Impact: New Cost Pressures and Strategic Supply Chain Evolution

The introduction of elevated United States tariffs in 2025 led to substantial cost impacts across the cystic fibrosis devices industry. Companies have responded with diversification in vendor management, nearshoring initiatives, and evaluation of domestic manufacturing options to strengthen supply chain resilience. Despite these efforts, reliance on certain specialized components produced abroad still poses risks, creating a strong incentive for dynamic sourcing models and co-development within tariff-exempt regions. These measures are critical for ensuring the agility and stability required in the evolving regulatory landscape.

Methodology & Data Sources

This analysis integrates comprehensive secondary research, including peer-reviewed studies, clinical guidelines, regulatory filings, and industry reports, with primary research gathered from over one hundred structured stakeholder interviews and quantitative surveys. Data triangulation and advanced statistical modeling (regression, scenario simulation) provide accuracy and reliability for segmentation and forecast assessments.

Why This Report Matters

  • Enables senior executives to understand the interplay of regulatory shifts, technology innovation, and regional market nuances for better strategic planning.
  • Supports investment decisions by synthesizing actionable insights on device adoption, supply chain agility, and differentiation opportunities.
  • Guides product development teams toward effective alignment with payer expectations, patient needs, and evolving approval requirements in core and emerging markets.

Conclusion

The cystic fibrosis devices market presents a dynamic environment shaped by innovation, digital integration, and new trade realities. Informed leaders leveraging tailored strategies will be best positioned to advance patient care and capture future growth opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of smart nebulizer technologies with real time usage tracking and patient adherence analytics
5.2. Development of portable high frequency chest wall oscillation devices for enhanced home airway clearance therapy
5.3. Collaboration between device manufacturers and gene therapy developers to integrate targeted CFTR delivery systems
5.4. Advances in dry powder inhaler formulations coupled with novel spacer designs to optimize CFTR modulator deposition
5.5. Emergence of telemedicine enabled respiratory physiotherapy platforms with integrated wearable cough monitoring sensors
5.6. Implementation of patient centric design enhancements focused on reducing treatment time and improving user comfort
5.7. Regulatory harmonization and reimbursement strategies accelerating market access for innovative CF inhalation devices
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cystic Fibrosis Devices Market, by Product Type
8.1. Introduction
8.2. Diagnostic
8.3. Pulmonary Delivery
8.3.1. Dry Powder Inhalers
8.3.2. Inhalers
8.3.2.1. Metered Dose Inhalers
8.3.2.2. Soft Mist Inhalers
8.3.3. Nebulizers
8.3.3.1. Jet Nebulizers
8.3.3.2. Mesh Nebulizers
8.3.3.3. Ultrasonic Nebulizers
9. Cystic Fibrosis Devices Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
9.5. Specialty Centers
10. Cystic Fibrosis Devices Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospital
11. Cystic Fibrosis Devices Market, by Modality
11.1. Introduction
11.2. Invasive
11.3. Non Invasive
12. Cystic Fibrosis Devices Market, by Component
12.1. Introduction
12.2. Pumps
12.2.1. Peristaltic Pumps
12.2.2. Syringe Pumps
12.3. Sensors
12.3.1. Flow Sensors
12.3.2. Pressure Sensors
12.4. Valves
13. Cystic Fibrosis Devices Market, by Patient Type
13.1. Introduction
13.2. Adult
13.3. Pediatric
14. Americas Cystic Fibrosis Devices Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cystic Fibrosis Devices Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cystic Fibrosis Devices Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Koninklijke Philips N.V.
17.3.2. Baxter International Inc.
17.3.3. Drive DeVilbiss Healthcare, Inc.
17.3.4. PARI GmbH
17.3.5. Vyaire Medical, Inc.
17.3.6. Smiths Group plc
17.3.7. Teleflex Incorporated
17.3.8. Omron Corporation
17.3.9. ResMed Inc.
17.3.10. Fisher & Paykel Healthcare Corporation Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CYSTIC FIBROSIS DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CYSTIC FIBROSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CYSTIC FIBROSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CYSTIC FIBROSIS DEVICES MARKET: RESEARCHAI
FIGURE 28. CYSTIC FIBROSIS DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 29. CYSTIC FIBROSIS DEVICES MARKET: RESEARCHCONTACTS
FIGURE 30. CYSTIC FIBROSIS DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CYSTIC FIBROSIS DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PERISTALTIC PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PERISTALTIC PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY FLOW SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY FLOW SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRESSURE SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRESSURE SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY VALVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY VALVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CYSTIC FIBROSIS DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 138. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 139. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 140. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 141. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 142. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 143. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 148. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 149. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 150. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 151. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 152. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 153. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 154. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 155. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 172. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 173. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 272. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 273. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 282. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 283. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 284. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 285. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 286. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 290. GERMANY CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 291. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 294. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 295. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 298. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 299. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 304. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 305. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 306. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 307. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 308. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 309. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 310. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 311. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 312. FRANCE CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PULMONARY DELIVERY, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY MODALITY, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA CYSTIC FIBROSIS DEVICES MARKET SIZE, BY PUMPS, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA CYSTIC FIBROSIS

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Cystic Fibrosis Devices market report include:
  • Koninklijke Philips N.V.
  • Baxter International Inc.
  • Drive DeVilbiss Healthcare, Inc.
  • PARI GmbH
  • Vyaire Medical, Inc.
  • Smiths Group plc
  • Teleflex Incorporated
  • Omron Corporation
  • ResMed Inc.
  • Fisher & Paykel Healthcare Corporation Limited

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.05 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report - Product Image

Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Cystic Fibrosis Market by Product Type (Anti Inflammatories, Antibiotics, CFTR Modulator Therapy), Route Of Administration (Inhalation, Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cystic Fibrosis Market by Product Type (Anti Inflammatories, Antibiotics, CFTR Modulator Therapy), Route Of Administration (Inhalation, Intravenous, Oral), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis Market Report 2025 - Product Image

Non-Cystic Fibrosis Bronchiectasis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Airway Clearance Devices for Cystic Fibrosis Market Report 2025 - Product Image

Airway Clearance Devices for Cystic Fibrosis Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From

About the Cystic Fibrosis Devices Market

The Cystic Fibrosis Devices market is a subset of the larger Respiratory Devices market. It includes devices used to diagnose, monitor, and treat cystic fibrosis, a genetic disorder that affects the lungs and digestive system. Diagnostic devices include sweat chloride tests and genetic tests, while monitoring devices include spirometers and pulse oximeters. Treatment devices include nebulizers, inhalers, and airway clearance systems. These devices are used to help manage the symptoms of cystic fibrosis, such as coughing, wheezing, and difficulty breathing. Some companies in the Cystic Fibrosis Devices market include Philips Respironics, ResMed, and Fisher & Paykel Healthcare. Other companies include Inogen, Invacare, and Vyaire Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.